Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Natural Cycle IUI
NCT04169451Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of letrozole in Unexplained infertility and infertility (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Live Birth Rate at 14 months. Started Sep 2022; status: recruiting.
02
Drugs
letrozole
03
Conditions
Unexplained infertilityinfertility
Beyond the preview
Go deeper on NCT04169451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169451.